Tingley Whittemore 4
4 · Tenaya Therapeutics, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Tenaya Therapeutics (TNYA) CMO Tingley Whittemore Sells Shares
What Happened Tingley Whittemore, Chief Medical Officer of Tenaya Therapeutics (TNYA), sold 3,121 common shares on May 18, 2026, at $0.79 per share for a total of $2,477. The filing (Form 4) reports this was a sale to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs).
Key Details
- Transaction date: 2026-05-18; sale price: $0.79/share; shares sold: 3,121; proceeds: ~$2,477. (Transaction code: S)
- Footnote F1: Shares were sold to cover tax withholding on RSUs that vested (award dated January 24, 2025).
- Footnote F2: Reporting person has 112,919 shares of common stock that will be issued upon vesting of RSUs.
- Filing date: 2026-05-19 — the Form 4 was filed the next day and is timely (no late filing noted).
Context This was a tax-withholding sale (routine) tied to RSU vesting rather than a market-driven disposition of an existing stake. Such sales are commonly administrative and do not necessarily signal a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Tingley Whittemore
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-18$0.79/sh−3,121$2,477→ 215,497 total
Footnotes (2)
- [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
- [F2]Includes 112,919 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact|2026-05-19